CIK 0001706431 · Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812730369
- Phone
- 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,939
- in 1 filing, $42K under 10b5-1 plans
Net −$41,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 46 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-19 | SATO VICKI L Director | Sale | −8,328 | $43.35 | $361K | 1,660,782 |
| 2021-05-19 | SATO VICKI L Director | Sale | −5,403 | $44.18 | $239K | 1,655,379 |
| 2021-05-19 | SATO VICKI L Director | Sale | −1,443 | $44.96 | $65K | 1,653,936 |
| 2021-05-18 | Virgin Herbert EVP, Research & CSO | Option exercise | +1,375 | $1.53 | $2K | 93,075 |
| 2021-05-18 | Virgin Herbert EVP, Research & CSO | Sale | −1,375 | $45.03 | $62K | 91,700 |
| 2021-05-18 | Virgin Herbert EVP, Research & CSO | Option exercise · Stock Option (Right to Buy) | −1,375 | 301,505 | ||
| 2021-05-04 | Virgin Herbert EVP, Research & CSO | Option exercise | +1,375 | $1.53 | $2K | 93,075 |
| 2021-05-04 | Virgin Herbert EVP, Research & CSO | Sale | −1,375 | $46.03 | $63K | 91,700 |
| 2021-05-04 | Virgin Herbert EVP, Research & CSO | Option exercise · Stock Option (Right to Buy) | −1,375 | 302,880 | ||
| 2021-04-27 | Virgin Herbert EVP, Research & CSO | Option exercise | +7,900 | $1.53 | $12K | 99,600 |
| 2021-04-27 | Virgin Herbert EVP, Research & CSO | Sale | −7,900 | $49.50 | $391K | 91,700 |
| 2021-04-27 | Virgin Herbert EVP, Research & CSO | Option exercise · Stock Option (Right to Buy) | −7,900 | 304,255 | ||
| 2021-04-19 | Virgin Herbert EVP, Research & CSO | Option exercise | +2,340 | $1.53 | $4K | 94,040 |
| 2021-04-19 | Virgin Herbert EVP, Research & CSO | Sale | −2,340 | $48.00 | $112K | 91,700 |
| 2021-04-19 | Virgin Herbert EVP, Research & CSO | Option exercise · Stock Option (Right to Buy) | −2,340 | 312,155 | ||
| 2021-04-16 | Virgin Herbert EVP, Research & CSO | Option exercise | +3,500 | $1.53 | $5K | 91,700 |
| 2021-04-16 | Virgin Herbert EVP, Research & CSO | Option exercise · Stock Option (Right to Buy) | −3,500 | 314,495 | ||
| 2021-04-13 | Virgin Herbert EVP, Research & CSO | Option exercise | +5,560 | $1.53 | $9K | 93,760 |
| 2021-04-13 | Virgin Herbert EVP, Research & CSO | Sale | −5,560 | $43.57 | $242K | 88,200 |
| 2021-04-13 | Virgin Herbert EVP, Research & CSO | Option exercise · Stock Option (Right to Buy) | −5,560 | 317,995 |
Page 42 of 54 · 1,063 trades